Annual report pursuant to Section 13 and 15(d)

SHARE-BASED COMPENSATION (Details)

SHARE-BASED COMPENSATION (Details)															1 Months Ended		12 Months Ended
SHARE-BASED COMPENSATION (Details)	May. 20, 2015 $ / shares shares	Apr. 14, 2015 Employee $ / shares shares	Feb. 12, 2015 $ / shares shares	Feb. 10, 2015 $ / shares shares	Feb. 21, 2014 USD ($) $ / shares shares	May. 29, 2013 USD ($) $ / shares shares	Nov. 15, 2012 USD ($) $ / shares shares	Sep. 25, 2011 $ / shares shares	May. 20, 2011 $ / shares shares	May. 02, 2011 $ / shares shares	Jan. 12, 2011 USD ($) $ / shares shares	Feb. 28, 2010 USD ($)	Feb. 23, 2010 $ / shares	Jul. 31, 2009 Option $ / shares shares	Oct. 31, 2014 USD ($) shares	Feb. 28, 2010 shares	Dec. 31, 2015 USD ($) $ / shares shares	Dec. 31, 2014 USD ($) $ / shares shares	Dec. 31, 2013 USD ($) $ / shares	Dec. 31, 2012 USD ($)	Dec. 31, 2015 USD ($) $ / shares shares	May. 08, 2013 shares	Feb. 01, 2013 $ / shares shares	Oct. 23, 2008 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 2,353,000	$ 2,141,000	$ 1,215,000
Warrants and Rights Note Disclosure [Abstract]
Common stock, issued (in shares)																							100,000
Strike price (in dollars per share) \| $ / shares																							$ 10.00
Warrant term																	5 years
Vesting percentage																	50.00%
Vesting of warrant in year one, description																	equal increments of 1/12th each calendar month throughout the first year
Vesting of warrant thereafter, description																	equal increments of 1/36th each calendar month over years 2 through 4 contingent upon continuous investor relations service under the consulting agreement
Investor relations expense \| $																		$ 79,000	180,000
Warrant [Member]
Weighted Average Grant Date Price per Share [Abstract]
Number of shares of common stock issued (in shares)																	0
Restricted Stock [Member]
Shares of Restricted Stock [Roll Forward]
Outstanding at beginning of period (in shares)																	0
Granted (in shares)																	167,040
Vested (in shares)																	(19,000)
Outstanding at end of period (in shares)																	148,040	0
Expected to vest (in shares)																	148,040				148,040
Weighted Average Grant Date Price per Share [Abstract]
Outstanding at beginning of period (in dollars per share) \| $ / shares																	$ 0
Granted (in dollars per share) \| $ / shares																	14.15
Vested (in dollars per share) \| $ / shares																	14.22
Outstanding at end of period (in dollars per share) \| $ / shares																	$ 14.14	$ 0
Unrecognized compensation cost related to non-vested share-based compensation \| $																					$ 1,700,000
Weighted average recognition period																	3 years 3 months 18 days
Stock Options [Roll Forward]
Expected to vest, end of period (in shares)																	148,040
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 1,645,000	$ 2,063,000	$ 1,214,000
Shares of Restricted Stock [Roll Forward]
Expected to vest (in shares)																	522,500				522,500
Weighted Average Grant Date Price per Share [Abstract]
Unrecognized compensation cost related to non-vested share-based compensation \| $																					$ 2,900,000
Weighted average recognition period																	2 years
Number of shares of common stock issued (in shares)																	0
Number of shares register under stock option plans (in shares)																						1,500,000		1,000,000
Exercise price (in dollars per share) \| $ / shares																	$ 0
Aggregate options outstanding (in shares)																	1,598,191	1,598,191			1,376,437
Stock Options [Roll Forward]
Outstanding at beginning of period (in shares)																	1,598,191
Granted (in shares)																	0
Expired (in shares)																	0
Exercised (in shares)																	(221,754)
Forfeited (in shares)																	0
Outstanding at end of period (in shares)																	1,376,437	1,598,191
Expected to vest, end of period (in shares)																	522,500
Exercisable, end of period (in shares)																	653,937
Weighted Average Exercise Price Per Share [Roll Forward]
Outstanding at beginning of period (in dollars per share) \| $ / shares																	$ 7.16
Granted (in dollars per share) \| $ / shares																	0
Expired (in dollars per share) \| $ / shares																	0
Exercised (in dollars per share) \| $ / shares																	3.94
Forfeited (in dollars per share) \| $ / shares																	0
Outstanding at end of period (in dollars per share) \| $ / shares																	7.68	$ 7.16
Expected to vest, end of period (in dollars of period) \| $ / shares																	$ 10.63
Exercisable, end of period (in dollars per share) \| $ / shares																					$ 6.63
Weighted Average Remaining Contractual Life [Abstract]
Outstanding, weighted average remaining contractual life																	6 years 1 month 6 days
Expected to vest, weighted average remaining contractual life																	7 years 9 months 18 days
Exercisable, weighted average remaining contractual life																	5 years 7 months 6 days
Intrinsic Value [Abstract]
Outstanding, Intrinsic value \| $																					$ 6,483,000
Expected to vest, Intrinsic value \| $																					920,000
Exercisable, Intrinsic value \| $																					$ 3,767,000
Options and warrants shares to purchase in the money (in shares)																					1,400,000
Weighted average grant date fair value of options (in dollars per share) \| $ / shares																	$ 0	$ 12.26	$ 7.71
Aggregate intrinsic value of options exercised \| $																	$ 2,300,000	$ 1,600,000	$ 142,000
Cash received upon exercise of options \| $																	$ 123,000	$ 91,000	$ 60,000
Shares [Rollforward]
Non-vested, beginning of period (in shares)																	825,250
Granted (in shares)																	0
Forfeited (in shares)																	0
Vested (in shares)																	(325,250)
Non-vested, end of period (in shares)																	500,000	825,250
Weighted Average Grant-Date Fair Value Per Share [Rollforward]
Non-vested, at beginning of period (in dollars per share) \| $ / shares																	$ 9.59
Granted (in dollars per share) \| $ / shares																	0	$ 12.26	$ 7.71
Forfeited (in dollars per share) \| $ / shares																	0
Vested (in dollars per share) \| $ / shares																	7.79
Non-vested, end of period (in dollars per share) \| $ / shares																	$ 10.76	$ 9.59
Fair value of options vested in period \| $																		$ 1,496,000
Director [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 43,000
Shares of Restricted Stock [Roll Forward]
Granted (in shares)	30,000
Weighted Average Grant Date Price per Share [Abstract]
Granted (in dollars per share) \| $ / shares	$ 12.39
Vesting percentage	20.00%
Vesting period																	5 years
Employees [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 12,000
Shares of Restricted Stock [Roll Forward]
Granted (in shares)		1,000
Weighted Average Grant Date Price per Share [Abstract]
Granted (in dollars per share) \| $ / shares		$ 12.03
Number of employees \| Employee		2
Years with the company																	30 years
Officer and Key Employees [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 395,000
Shares of Restricted Stock [Roll Forward]
Granted (in shares)				118,040
Weighted Average Grant Date Price per Share [Abstract]
Granted (in dollars per share) \| $ / shares				$ 14.59
Vesting percentage				25.00%
Vesting period																	4 years
Executive Vice President [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $															$ 79,310
Weighted Average Grant Date Price per Share [Abstract]
Number of shares of common stock issued (in shares)															7,000
Non-Employee Director [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 9,000	66,000	$ 113,000
Weighted Average Grant Date Price per Share [Abstract]
Exercise price (in dollars per share) \| $ / shares													$ 2.82
Vesting period																5 years
Expected dividends \| $												$ 0
Stock Options [Roll Forward]
Granted (in shares)																500,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares													$ 2.82
Shares [Rollforward]
Granted (in shares)																500,000
Non-Employee Director [Member] \| Stock Options [Member] \| Minimum [Member]
Weighted Average Grant Date Price per Share [Abstract]
Expected volatility												338.00%
Expected term (in years)												5 years
Risk free interest rate												2.37%
Non-Employee Director [Member] \| Stock Options [Member] \| Maximum [Member]
Weighted Average Grant Date Price per Share [Abstract]
Expected volatility												467.00%
Expected term (in years)												10 years
Risk free interest rate												3.68%
Director Joseph Palm [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	0	0	0
Weighted Average Grant Date Price per Share [Abstract]
Options awarded, term								10 years	10 years
Exercise price (in dollars per share) \| $ / shares								$ 3.52	$ 3.90
Vesting period								4 years 8 months 1 day	1 year
Aggregate options outstanding (in shares)									100,000
Share lots vesting (in shares)																					20,000
Stock Options [Roll Forward]
Granted (in shares)								80,000	19,333
Outstanding at end of period (in shares)									100,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares								$ 3.52	$ 3.90
Shares [Rollforward]
Granted (in shares)								80,000	19,333
Director Joseph Palm [Member] \| Stock Options [Member] \| Stock Options Issued on September 25, 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	65,000	65,000	65,000
Director John Townsend [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	80,000	80,000	80,000
Weighted Average Grant Date Price per Share [Abstract]
Options awarded, term										10 years
Exercise price (in dollars per share) \| $ / shares										$ 4.09
Vesting percentage										20.00%
Vesting period										5 years
Stock Options [Roll Forward]
Granted (in shares)										100,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares										$ 4.09
Shares [Rollforward]
Granted (in shares)										100,000
Key Employees [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	40,000	475,000	475,000
Weighted Average Grant Date Price per Share [Abstract]
Options awarded, term											10 years
Exercise price (in dollars per share) \| $ / shares											$ 4.86
Vesting percentage											25.00%
Vesting period											4 years
Expected dividends \| $											$ 0
Stock Options [Roll Forward]
Granted (in shares)											391,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares											$ 4.86
Shares [Rollforward]
Granted (in shares)											391,000
Key Employees [Member] \| Stock Options [Member] \| Minimum [Member]
Weighted Average Grant Date Price per Share [Abstract]
Expected volatility											96.00%
Expected term (in years)											5 years
Risk free interest rate											1.26%
Key Employees [Member] \| Stock Options [Member] \| Maximum [Member]
Weighted Average Grant Date Price per Share [Abstract]
Expected volatility											413.00%
Expected term (in years)											10 years
Risk free interest rate											3.34%
Director Gary Adams [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	120,000	120,000	120,000
Weighted Average Grant Date Price per Share [Abstract]
Options awarded, term							10 years
Exercise price (in dollars per share) \| $ / shares							$ 7.14
Vesting percentage							20.00%
Vesting period							5 years
Expected volatility							87.00%
Expected dividends \| $							$ 0
Expected term (in years)							6 years 6 months
Risk free interest rate							0.92%
Stock Options [Roll Forward]
Granted (in shares)							100,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares							$ 7.14
Shares [Rollforward]
Granted (in shares)							100,000
Mr. Hatem El Khalidi [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	97,000	97,000	97,000
Weighted Average Grant Date Price per Share [Abstract]
Number of options awarded \| Option														2
Compensation expense reversed \| $																				$ 413,000
Stock Options [Roll Forward]
Granted (in shares)														200,000
Intrinsic Value [Abstract]
Weighted average grant date fair value of options (in dollars per share) \| $ / shares														$ 3.40
Shares [Rollforward]
Granted (in shares)														200,000
Weighted Average Grant-Date Fair Value Per Share [Rollforward]
Granted (in dollars per share) \| $ / shares														$ 3.40
Simon Upfill-Brown [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	126,000	126,000	$ 84,000
Weighted Average Grant Date Price per Share [Abstract]
Options awarded, term						10 years
Exercise price (in dollars per share) \| $ / shares						$ 7.71
Vesting percentage						25.00%
Vesting period						4 years
Expected volatility						85.00%
Expected dividends \| $						$ 0
Expected term (in years)						6 years 3 months
Risk free interest rate						1.33%
Stock Options [Roll Forward]
Granted (in shares)						90,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares						$ 7.71
Shares [Rollforward]
Granted (in shares)						90,000
Various Employees [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	258,000
Shares of Restricted Stock [Roll Forward]
Granted (in shares)			18,000
Weighted Average Grant Date Price per Share [Abstract]
Granted (in dollars per share) \| $ / shares			$ 14.34
Various Employees [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense \| $																	$ 1,108,000	$ 955,000
Weighted Average Grant Date Price per Share [Abstract]
Options awarded, term					10 years
Exercise price (in dollars per share) \| $ / shares					$ 12.26
Vesting percentage					25.00%
Vesting period					4 years
Expected volatility					84.00%
Expected dividends \| $					$ 0
Expected term (in years)					6 years 3 months
Risk free interest rate					1.95%
Stock Options [Roll Forward]
Granted (in shares)					500,000
Weighted Average Exercise Price Per Share [Roll Forward]
Granted (in dollars per share) \| $ / shares					$ 12.26
Shares [Rollforward]
Granted (in shares)					500,000